Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
Shuying Feng, Zilong Wang, Aifang Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 21

Showing 21 citing articles:

Principles of CRISPR-Cas9 technology: Advancements in genome editing and emerging trends in drug delivery
Alaa A. A. Aljabali, Mohamed El‐Tanani, Murtaza M. Tambuwala
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105338-105338
Open Access | Times Cited: 39
New Frontiers in CRISPR: Addressing Antimicrobial Resistance with Cas9, Cas12, Cas13, and Cas14
Ahmed S.A. Ali Agha, Ali Al‐Samydai, Talal Aburjaı
Heliyon (2025) Vol. 11, Iss. 2, pp. e42013-e42013
Open Access | Times Cited: 2
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 21
A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
Shuying Feng, Xin Xie, Junjie Liu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Optimization of a CRISPR-Cas9 in vitro protocol for targeting the SIX9 gene of Fusarium oxysporum f.sp. cubense race 1 associated with banana Fusarium wilt
Liliana Villao-Uzho, Jeffrey Vargas, Nardy Dı́ez, et al.
Frontiers in Plant Science (2025) Vol. 16
Open Access
Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer
Nihar Godbole, Alexander Quinn, Flavio Carrión, et al.
Seminars in Cancer Biology (2023) Vol. 96, pp. 64-81
Closed Access | Times Cited: 9
Development of a CRISPR-Cas12a system for efficient genome engineering in clostridia
Yanchao Zhang, Aleksandra M. Kubiak, Tom S. Bailey, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 9
CRISPR/Cas9: a powerful tool in colorectal cancer research
Yang Hu, Liang Liu, Qi Jiang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 8
Decrypting the mechanistic basis of CRISPR/Cas9 protein
Gayatri Panda, Arjun Ray
Progress in Biophysics and Molecular Biology (2022) Vol. 172, pp. 60-76
Closed Access | Times Cited: 8
Selecting for CRISPR-Edited Knock-In Cells
Nina Reuven, Yosef Shaul
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11919-11919
Open Access | Times Cited: 8
Fast, precise and cloning-free knock-in of reporter sequences in vivo with high efficiency
Yiran Zhang, Katy LH Marshall-Phelps, Rafael Almeida
Development (2023) Vol. 150, Iss. 12
Open Access | Times Cited: 4
Engineering megabase-sized genomic deletions with MACHETE (Molecular Alteration of Chromosomes with Engineered Tandem Elements)
Francisco M. Barriga, Scott W. Lowe
Nature Protocols (2024) Vol. 19, Iss. 5, pp. 1381-1399
Closed Access | Times Cited: 1
A calibrated cell‐based functional assay to aid classification of MLH1 DNA mismatch repair gene variants
Abhijit Rath, Alexander A. Radecki, Kaussar Rahman, et al.
Human Mutation (2022) Vol. 43, Iss. 12, pp. 2295-2307
Open Access | Times Cited: 7
Application of CRISPR–Cas Technology in Drug Development
Sidra Altaf, Faiza Saleem, H Ikram, et al.
(2024), pp. 203-245
Closed Access
Optimized CRISPR-Based Knockout in BeWo Cells
Eric Yin, Meagan N. Esbin
Placenta (2024)
Closed Access
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression
Vincenzo Davide Pantina, Francesco Verona, Alice Turdo, et al.
STAR Protocols (2024) Vol. 5, Iss. 3, pp. 103263-103263
Closed Access
Advances in CRISPR/Cas systems-based cell and gene therapy
Arpita Poddar, Farah Ahmady, Prashanth Prithviraj, et al.
Progress in molecular biology and translational science (2024), pp. 161-183
Closed Access
In Vitro Mutagenesis: A Non-invasive Technology for Effective Crop Improvement to Assure Food and Nutritional Security—Current Trends, Advancements and Future Perspectives
Vishal Sharma, Manisha Thakur, Sukhjinder Singh Maan, et al.
Journal of Plant Growth Regulation (2024)
Closed Access
The Powers and Perils of Bug Editing
Helena Araujo
Insect Biochemistry and Molecular Biology (2024), pp. 104253-104253
Closed Access
Edición de Genes y CRISPR-Cas: Aplicaciones, Avances y Desafíos: Genes y CRISPR
Joel Horacio Elizondo‐Luévano, Lizeth Aniram Garcia Sotelo, Ivan Cárdenas Paredes, et al.
(2024) Vol. 1, Iss. 2
Closed Access
CRISPR-gene-engineered CYBB knock-out PLB-985 cells, a useful model to study functional impact of X-linked chronic granulomatous disease mutations: application to the G412E X91+-CGD mutation
Sylvain Beaumel, Lucile Verbrugge, Franck Fieschi, et al.
Clinical & Experimental Immunology (2023) Vol. 212, Iss. 2, pp. 156-165
Closed Access | Times Cited: 1
Page 1

Scroll to top